Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya

Journal of Infectious Diseases

Volumn 206, Issue 7, 2012, Pages 1020-1029

  Abdullahi, Osman ^a,b   Karani, Angela ^a   Tigoi, Caroline C ^a   Mugo, Daisy ^a   Kungu, Stella ^a   Wanjiru, Eva ^a   Jomo, Jane ^a   Musyimi, Robert ^a   Lipsitch, Marc ^b   Scott, J Anthony G ^a,c  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM CULTURE; CHILD; CROSS-SECTIONAL STUDY; HUMAN; INFANT; KENYA; NASOPHARYNX; NONHUMAN; NOSE SMEAR; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

CARRIER STATE; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; KENYA; LONGITUDINAL STUDIES; NASOPHARYNGEAL DISEASES; PNEUMOCOCCAL INFECTIONS; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 84866071516     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis447     Document Type: Article

References (41)

1. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunoge-nicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente vaccine study center group. Pediatr Infect Dis J 2000; 19:187-95.
2. Cutts FT, Zaman SMA, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005; 365:1139-46. (Pubitemid 40417563)
3. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349:1341-8. (Pubitemid 37186212)
4. O'Brien KL, Moulton LH, Reid R, et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 2003; 362:355-61. (Pubitemid 36945058)
5. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54:893-7.
6. Miller E, Andrews N, Waight P, Slack M, George R. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011; 11:760-8.
7. Lexau CA, Lynfield R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294:2043-51. (Pubitemid 41539937)
8. Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006; 295:1668-74.
9. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a nonava-lent pneumococcal conjugate vaccine. J Infect Dis 1999; 180:1171-6. (Pubitemid 30070201)
10. Obaro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996; 348:271-2.
11. Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 2002; 185:927-36. (Pubitemid 34274436)
12. Cheung Y-B, Zaman SMA, Nsekpong ED, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Pediatr Infect Dis J 2009; 28:990-5.
13. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297:1784-92. (Pubitemid 46658647)
14. Weinberger D, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011; 378:1962-73.
15. Flasche S, Van Hoek AJ, Sheasby E, et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med 2011; 8:e1001017.
16. Weinberger DM, Harboe ZB, Flasche S, Scott JA, Lipsitch M. Prediction of serotypes causing invasive pneumococcal disease in unvacci-nated and vaccinated populations. Epidemiology 2011; 22:199-207.
17. Temime L, Guillemot D, Boelle PY. Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob Agents Chemother 2004; 48:2206-13. (Pubitemid 38691620)
18. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A 1997; 94:6571-6. (Pubitemid 27270726)
19. Melegaro A, Choi Y, Pebody R, Gay N. Pneumococcal carriage in United Kingdom families: estimating serotype-specific transmission parameters from longitudinal data. Am J Epidemiol 2007; 166:228-35. (Pubitemid 47227292)
20. Auranen K, Mehtala J, Tanskanen A, S Kaltoft M. Between-strain competition in acquisition and clearance of pneumococcal carriage\- epidemiologic evidence from a longitudinal study of day-care children. Am J Epidemiol 2010; 171:169-76.
21. Sleeman KL, Griffiths D, Shackley F, et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 2006; 194:682-8. (Pubitemid 44297855)
22. Yildirim I, Hanage WP, Lipsitch M, et al. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 2010; 29:283-8.
23. Auranen K, Arjay E, Leino T, Takala AK. Transmission of pneumococcal carriage in families: a latent Markov process model for binary longitudinal data. J Am Stat Assoc 2000; 95:1044-53.
24. Scott JA, Bauni E, Moisi J, et al. The Kilifi Health and Demographic Surveillance System (KHDSS). Int J Epidemiol 2012; 41:650-7.
25. Abdullahi O, Karani A, Tigoi CC, et al. The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya. PLoS One 2012; 7:e30787.
26. O'Brien KL, Nohynek H. The WHO pneumococcal vaccine trials carriage working group. Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneu-moniae. Pediatr Infect Dis J 2003; 22:133-40. (Pubitemid 36228130)
27. Freeman J, Hutchison GB. Prevalence, incidence and duration. Am J Epidemiol 1980; 112:707-23. (Pubitemid 11130684)
28. Tigoi CC, Gatakaa H, Karani A, et al. Rates of acquisition of pneumo-coccal colonization and transmission probabilities, by serotype, among newborn infants in Kilifi District, Kenya. Clin Infect Dis 2012; 55:180-8.
29. Melegaro A, Gay NJ, Medley GF. Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol Infect 2004; 132:433-41. (Pubitemid 38714119)
30. Hogberg L, Geli P, Ringberg H, Melander E, Lipsitch M, Ekdahl K. Age and serogroup related differences in the observed duration of nasopharyngeal carriage of penicillin-resistant pneumococci. J Clin Microbiol 2007; 45:948-52. (Pubitemid 46427716)
31. Hill PC, Townend J, Antonio M, et al. Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin Infect Dis 2010; 50:1468-76.
32. Smith T, Lehmann D, Montgomery J, Gratten M, Riley ID, Alpers MP. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 1993; 111:27-39. (Pubitemid 23241776)
33. Bogaert D, Weinberger D, Thompson C, Lipsitch M, Malley R. Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model. Infect Immun 2009; 77:1613-22.
34. Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci USA 2005; 102:4848-53. (Pubitemid 40471542)
35. Abdullahi O, Nyiro J, Lewa P, Slack M, Scott JAG. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influen-zae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J 2008; 27:59-64.
36. Lipsitch M, Abdullahi O, D'Amour A, et al. Rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kilifi District, Kenya: application of a Markov transition model. Epidemiology 2012; 23:510-9.
37. Montgomery JM, Lehmann D, Smith T, et al. Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in Highland children of Papua New Guinea. Rev Infect Dis 1990; 12(Suppl 8):S1006-16.
38. Smillie WG, Jewett OF. The relationship of immediate family contact to the transmission of type-specific pneumococci. Am J Hyg 1940; 32:79-88.
39. Vu HT, Yoshida LM, Suzuki M, et al. Association between nasopha-ryngeal load of Streptococcus pneumoniae, viral coinfection, and radio-logically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J 2011; 30:11-8.
40. Albrich WC, Madhi SA, Adrian PV, et al. Use of a rapid test of pneu-mococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis 2012; 54:601-9.
41. Abdullahi O, Wanjiru E, Musyimi R, Glass N, Scott JAG. Validation of nasopharyngeal sampling and culture techniques for detection of Streptococcus pneumoniae in children in Kenya. J Clin Microbiol 2007; 45:3408-10. (Pubitemid 47585673)